ASX - By Stock
|
PNV |
Re:
30th June 2023 Share Price Prediction
|
|
Josywales
|
118 |
39K |
3 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
118
|
39K
|
3
|
|
ASX - By Stock
|
IVZ |
Option Holder Forms
|
|
Josywales
|
0 |
541 |
6 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
0
|
541
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Application for quotation of securities - IVZ
|
|
Josywales
|
5 |
2.4K |
4 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
5
|
2.4K
|
4
|
|
ASX - By Stock
|
CCA |
Re:
Ann: Half Yearly Report and Accounts
|
|
Josywales
|
1 |
786 |
1 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
1
|
786
|
1
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Funding completed for mobilisation of drilling rig
|
|
Josywales
|
59 |
12K |
6 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
59
|
12K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
Ann: Invictus SPP total Increased to $4.0m & to close early
|
|
Josywales
|
358 |
78K |
4 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
358
|
78K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Retirement of Chief Medical Officer
|
|
Josywales
|
40 |
22K |
15 |
21/01/22 |
21/01/22 |
ASX - By Stock
|
40
|
22K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer
|
|
Josywales
|
252 |
135K |
83 |
16/11/21 |
16/11/21 |
ASX - By Stock
|
252
|
135K
|
83
|
|
ASX - By Stock
|
IMU |
Re:
IMUOC oppies - severly undervalued
|
|
Josywales
|
93 |
52K |
1 |
06/08/21 |
06/08/21 |
ASX - By Stock
|
93
|
52K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar with Celularity Dr Robert Hariri
|
|
Josywales
|
51 |
18K |
18 |
05/08/21 |
05/08/21 |
ASX - By Stock
|
51
|
18K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Trading Halt
|
|
Josywales
|
414 |
200K |
7 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
414
|
200K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Josywales
|
1.6K |
462K |
3 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
1.6K
|
462K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proposed issue of Securities - OCC
|
|
Josywales
|
16 |
6.0K |
1 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
16
|
6.0K
|
1
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Proposed issue of Securities - OCC
|
|
Josywales
|
16 |
6.0K |
1 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
16
|
6.0K
|
1
|
|
ASX - By Stock
|
CCA |
Re:
Ann: Strategic Partnership & Licensing Agreement
|
|
Josywales
|
16 |
5.2K |
3 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
16
|
5.2K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Josywales
|
13K |
6.2M |
29 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
29
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Josywales
|
13K |
6.2M |
20 |
29/05/21 |
29/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
20
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
Josywales
|
22K |
11M |
9 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
22K
|
11M
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Josywales
|
13K |
6.2M |
19 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Josywales
|
13K |
6.2M |
1 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Josywales
|
13K |
6.2M |
3 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
13K
|
6.2M
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS
|
|
Josywales
|
346 |
179K |
3 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
346
|
179K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE LICENSES CAR T DIRECTED OV THERAPY FOR SOLID TUMOURS
|
|
Josywales
|
346 |
179K |
6 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
346
|
179K
|
6
|
|
ASX - By Stock
|
IVZ |
Re:
New Invictus Energy website
|
|
Josywales
|
19 |
6.8K |
3 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
19
|
6.8K
|
3
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro gains Australian reimbursement
|
|
Josywales
|
40 |
12K |
7 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
40
|
12K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene announces clinical milestone for HER-Vaxx
|
|
Josywales
|
214 |
110K |
25 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
214
|
110K
|
25
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene announces clinical milestone for HER-Vaxx
|
|
Josywales
|
214 |
110K |
10 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
214
|
110K
|
10
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene announces clinical milestone for HER-Vaxx
|
|
Josywales
|
214 |
110K |
9 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
214
|
110K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene announces clinical milestone for HER-Vaxx
|
|
Josywales
|
214 |
110K |
14 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
214
|
110K
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene announces clinical milestone for HER-Vaxx
|
|
Josywales
|
214 |
110K |
5 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
214
|
110K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Appendix 2A
|
|
Josywales
|
2 |
1.6K |
0 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
2
|
1.6K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Josywales
|
253 |
82K |
20 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
253
|
82K
|
20
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Josywales
|
306 |
143K |
1 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
306
|
143K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Josywales
|
253 |
82K |
0 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
82K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Josywales
|
253 |
82K |
14 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
82K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Josywales
|
253 |
82K |
23 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
82K
|
23
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro gains Australian reimbursement
|
|
Josywales
|
40 |
12K |
9 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
40
|
12K
|
9
|
|
ASX - By Stock
|
OCC |
Re:
Ann: CelGro gains Australian reimbursement
|
|
Josywales
|
40 |
12K |
7 |
03/03/21 |
03/03/21 |
ASX - By Stock
|
40
|
12K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
Josywales
|
1.6K |
462K |
2 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
1.6K
|
462K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Josywales
|
20K |
6.9M |
5 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
20K
|
6.9M
|
5
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Josywales
|
306 |
143K |
5 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
306
|
143K
|
5
|
|
ASX - By Stock
|
IIQ Biotech |
Re:
Pending testing results
|
|
Josywales
|
306 |
143K |
4 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
306
|
143K
|
4
|
|
ASX - By Stock
|
PET |
Re:
Ann: Extension of time to lodge full year accounts
|
|
Josywales
|
38 |
15K |
6 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
38
|
15K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Josywales
|
133 |
53K |
2 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
2
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Josywales
|
133 |
53K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
Josywales
|
133 |
53K |
10 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
133
|
53K
|
10
|
|
ASX - By Stock
|
PNV |
Re:
Ann: H1 FY21 Results Investor Presentation
|
|
Josywales
|
334 |
100K |
6 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
334
|
100K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Positive Early Preclinical Ovarian Cancer Results
|
|
Josywales
|
85 |
28K |
17 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
85
|
28K
|
17
|
|
ASX - By Stock
|
CCA |
Re:
Ann: Response to ASX Price and Volume Query
|
|
Josywales
|
127 |
32K |
7 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
127
|
32K
|
7
|
|
ASX - By Stock
|
CCA |
Re:
Ann: Response to ASX Price and Volume Query
|
|
Josywales
|
127 |
32K |
9 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
127
|
32K
|
9
|
|